Cite
Blockade of the spinal BDNF-activated JNK pathway prevents the development of antiretroviral-induced neuropathic pain.
MLA
Sanna, Maria Domenica, et al. “Blockade of the Spinal BDNF-Activated JNK Pathway Prevents the Development of Antiretroviral-Induced Neuropathic Pain.” Neuropharmacology, vol. 105, June 2016, pp. 543–52. EBSCOhost, https://doi.org/10.1016/j.neuropharm.2016.02.016.
APA
Sanna, M. D., Ghelardini, C., & Galeotti, N. (2016). Blockade of the spinal BDNF-activated JNK pathway prevents the development of antiretroviral-induced neuropathic pain. Neuropharmacology, 105, 543–552. https://doi.org/10.1016/j.neuropharm.2016.02.016
Chicago
Sanna, Maria Domenica, Carla Ghelardini, and Nicoletta Galeotti. 2016. “Blockade of the Spinal BDNF-Activated JNK Pathway Prevents the Development of Antiretroviral-Induced Neuropathic Pain.” Neuropharmacology 105 (June): 543–52. doi:10.1016/j.neuropharm.2016.02.016.